Artificial Intelligence In Medicine Market Size, Share 2021 Industry Growing Rapidly with Recent Demand, Trends, Development and Revenue


Posted December 14, 2021 by Absolute

Artificial Intelligence In Medicine Market Size, Share 2021 Industry Growing Rapidly with Recent Demand, Trends, Development and Revenue
 
The study conducted for Artificial Intelligence In Medicine industry also analyzes the market status, growth rate, future trends, market drivers, opportunities & challenges, risks & entry barriers, sales channels, & distributors with the help of SWOT analysis & Porter’s Five Forces Analysis. Artificial Intelligence In Medicine market research report bestows clients with the best results & for the same it has been produced by using integrated approaches & latest technology. This collected information is checked & verified by market experts before presenting it to the end user. Businesses are highly relying on the different segments covered in the market research report which gives better insights to drive the business into right direction.

The market studies, insights & analysis carried out in this Artificial Intelligence In Medicine market research report keeps marketplace clearly into the focus which helps achieve business goal. This Artificial Intelligence In Medicine market report is built by chewing over several fragments of the present & upcoming market scenario because an utter way to forecast what future holds is to comprehend the trend today. It all-inclusively estimates general market conditions, the growth prospects in the market, possible restrictions, significant industry trends, market size, market share, sales volume & future trends. This Artificial Intelligence In Medicine report is a wonderful guide for an actionable ideas, enhanced decision-making & better business strategies.

Get More Information : https://www.absolutemarketsinsights.com/reports/Artificial-Intelligence-in-Medicine-Market-2019-2027--513

In terms of revenue, the global artificial intelligence in medicine market was valued at US$ 1,798.22 Mn in 2018 and is growing at a CAGR of 49.4% over the forecast period. Some of the players operating in the artificial intelligence in medicine market are Bay Labs, Inc, CloudMedx Inc., Enclitic, General Electric, General Vision, Google LLC, IBM Corporation, iCarbonX, Koninklijke Philips, maxQ, Microsoft, Next IT Corp., Nvidia Corporation, Siemens Healthcare GmbH, and Welltok amongst others.

Artificial intelligence in medicine is generally referred as the use of artificial intelligence technologies or the automated processes in the diagnosis of symptoms and treatment of patients who require medical aid. Apart from diagnosis and treatment, artificial intelligence in medicine can be applied in the automation of various other processes such as, gathering data from patient meetings and tests, processing and analyzing the results, using multiple sources of data to come to an accurate diagnosis, assisting in determination of an appropriate treatment method, and patient monitoring amongst others.

For instance, MGH Laboratory of Computer Science offers DXplain which is a decision support system that helps in explaining clinical indicators of diseases. Similarly OpenClinical offers GermWatcher, which is a system that scans microbiology culture data from a hospital's laboratory system, identifies those cultures which represent nosocomial infections and reports them to the U.S. National Centers for Disease Control and Prevention (CDC). Increasing efficiency in medical diagnosis due to the integration of artificial intelligence is majorly driving the artificial intelligence in medicine market.

Global Artificial Intelligence in Medicine Market:
By Component
o Hardware
o Software
o Service
By Technology
o Querying Method
o Natural Language Processing
o Context Aware Processing
o Speech Recognition
o Decision Management
o Others (Biometrics, AI Modeling, Etc.)
By Application
o Robot Assisted Surgery
o Virtual Nursing Assistants
o Administrative Workflow Assistance
o Fraud Detection
o Connected Machines
o Clinical Trial
o Preliminary Diagnosis
o Others (Dosage Error Reduction, Cybersecurity, Etc.)
By End Users
o Healthcare Provider
o Pharmaceutical & Biotechnology Company
o Patient
o Payer
By Geography
o North America
 US
 Canada
 Mexico
 Rest of North America
o Europe
 France
 The UK
 Spain
 Germany
 Italy
 Nordic Countries
 Denmark
 Finland
 Iceland
 Sweden
 Norway
 Benelux Union
 Belgium
 The Netherlands
 Luxembourg
 Rest of Europe
o Asia Pacific
 China
 Japan
 India
 New Zealand
 Australia
 South Korea
 Southeast Asia
 Indonesia
 Thailand
 Malaysia
 Singapore
 Rest of Southeast Asia
 Rest of Asia Pacific
o Middle East and Africa
 Saudi Arabia
 UAE
 Egypt
 Kuwait
 South Africa
 Rest of Middle East & Africa
o Latin America
 Brazil
 Argentina
 Rest of Latin America
Contact Us:
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By AMI
Country United States
Categories Blogging
Last Updated December 14, 2021